MEDEOR THERAPEUTICS
USPTO Trademark Record · Serial No. 86432464
Trademark details
It was initially claimed by Medeor Therapeutics, Inc. on 20141023.
That brand applies to the following goods and services:Blood and bone marrow for medical purposes, namely, processed blood and bone marrow for preventing and treating rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for control and suppression of the immune system; blood and bone marrow for medical purposes, namely, processed blood and bone marrow for induction of immune tolerance; blood and bone marrow for m, Medical services, namely, processing blood and bone marrow to prevent and treat rejection of transplanted kidneys, transplanted livers, transplanted hearts, and other transplanted organs; medical services, namely, processing blood and bone marrow for control and suppression of the immune system; medical services, namely, processing blood and bone marrow for immune destruction of cancer cells; medical services in the field of preventing and treating rejection of transplanted kidneys, transplanted.
Currently that trademark is represented by trademark attorney(s): Matthew J. Kuykendall.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the MEDEOR THERAPEUTICS trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
